ElagolixHormone TherapySafety Rating 8/10
Primary research areaEndometriosis-associated pain
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range150 mg once daily or 200 mg twice daily
AdministrationOral tablet
Safety8/10 · FDA-approved (Orilissa)
NCAA D1Banned
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Elagolix
Mechanism of action
Oral non-peptide GnRH receptor antagonist; dose-dependent estradiol suppression
Safety profile
Hot flashes, night sweats, bone density loss · Approved for endometriosis; bone loss with prolonged use; hepatotoxicity warning
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Elagolix below your target.
Related pages